These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
412 related articles for article (PubMed ID: 31585275)
1. Novel virosecurinine bivalent mimetics as potent reversal agents against P-glycoprotein-mediated multidrug resistance. Hou W; Meng Y; Xu XF; Huang ZX; Liu J; Wang ZY; Lin J; Chen WM Eur J Med Chem; 2019 Dec; 183():111726. PubMed ID: 31585275 [TBL] [Abstract][Full Text] [Related]
2. Glabridin resensitizes p-glycoprotein-overexpressing multidrug-resistant cancer cells to conventional chemotherapeutic agents. Qian J; Xia M; Liu W; Li L; Yang J; Mei Y; Meng Q; Xie Y Eur J Pharmacol; 2019 Jun; 852():231-243. PubMed ID: 30959046 [TBL] [Abstract][Full Text] [Related]
3. Bipiperidinyl derivatives of 23-hydroxybetulinic acid reverse resistance of HepG2/ADM and MCF-7/ADR cells. Zhang DM; Li YJ; Shu C; Ruan ZX; Chen WM; Yiu A; Peng YH; Wang J; Lan P; Yao Z; Fung KP; Fu LW; Chen ZS; Ye WC Anticancer Drugs; 2013 Jun; 24(5):441-54. PubMed ID: 23466650 [TBL] [Abstract][Full Text] [Related]
4. Reversing Multidrug Resistance in Chemo-resistant Human Lung Adenocarcinoma (A549/DOX) Cells by Algerian Propolis Through Direct Inhibiting the P-gp Efflux-pump, G0/G1 Cell Cycle Arrest and Apoptosis Induction. Kebsa W; Lahouel M; Rouibah H; Zihlif M; Ahram M; Abu-Irmaileh B; Mustafa E; Al-Ameer HJ; Al Shhab M Anticancer Agents Med Chem; 2018; 18(9):1330-1337. PubMed ID: 30088453 [TBL] [Abstract][Full Text] [Related]
5. BI-2865, a pan-KRAS inhibitor, reverses the P-glycoprotein induced multidrug resistance in vitro and in vivo. Yang Q; To KKW; Hu G; Fu K; Yang C; Zhu S; Pan C; Wang F; Luo K; Fu L Cell Commun Signal; 2024 Jun; 22(1):325. PubMed ID: 38872211 [TBL] [Abstract][Full Text] [Related]
6. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells. Wang TX; Yang XH Yao Xue Xue Bao; 2008 May; 43(5):461-6. PubMed ID: 18717331 [TBL] [Abstract][Full Text] [Related]
7. Reversal of P-glycoprotein mediated multidrug resistance in K562 cell line by a novel synthetic calmodulin inhibitor, E6. Zhu HJ; Wang JS; Guo QL; Jiang Y; Liu GQ Biol Pharm Bull; 2005 Oct; 28(10):1974-8. PubMed ID: 16204958 [TBL] [Abstract][Full Text] [Related]
8. Modulation of the spacer in N,N-bis(alkanol)amine aryl ester heterodimers led to the discovery of a series of highly potent P-glycoprotein-based multidrug resistance (MDR) modulators. Dei S; Braconi L; Trezza A; Menicatti M; Contino M; Coronnello M; Chiaramonte N; Manetti D; Perrone MG; Romanelli MN; Udomtanakunchai C; Colabufo NA; Bartolucci G; Spiga O; Salerno M; Teodori E Eur J Med Chem; 2019 Jun; 172():71-94. PubMed ID: 30947123 [TBL] [Abstract][Full Text] [Related]
9. Overcoming multidrug-resistance in vitro and in vivo using the novel P-glycoprotein inhibitor 1416. Xu Y; Zhi F; Xu G; Tang X; Lu S; Wu J; Hu Y Biosci Rep; 2012 Dec; 32(6):559-66. PubMed ID: 22757751 [TBL] [Abstract][Full Text] [Related]
10. Jatrophane diterpenoids as multidrug resistance modulators from Euphorbia sororia. Yang H; Mamatjan A; Tang D; Aisa HA Bioorg Chem; 2021 Jul; 112():104989. PubMed ID: 34022709 [TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and biological evaluation of chalcones as reversers of P-glycoprotein-mediated multidrug resistance. Yin H; Dong J; Cai Y; Shi X; Wang H; Liu G; Tang Y; Liu J; Ma L Eur J Med Chem; 2019 Oct; 180():350-366. PubMed ID: 31325783 [TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and evaluation of a novel series of inhibitors reversing P-glycoprotein-mediated multidrug resistance. Ghaleb H; Li H; Kairuki M; Qiu Q; Bi X; Liu C; Liao C; Li J; Hezam K; Huang W; Qian H Chem Biol Drug Des; 2018 Sep; 92(3):1708-1716. PubMed ID: 29786944 [TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and biological evaluation of N-(4-(2-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)phenyl)-4-oxo-3,4-dihydrophthalazine-1-carboxamide derivatives as novel P-glycoprotein inhibitors reversing multidrug resistance. Qiu Q; Zhou J; Shi W; Kairuki M; Huang W; Qian H Bioorg Chem; 2019 May; 86():166-175. PubMed ID: 30710850 [TBL] [Abstract][Full Text] [Related]
14. The novel bis-benzylisoquinoline PY35 reverses P-glycoprotein-mediated multidrug resistance. Cao Z; Wright M; Cheng J; Huang X; Liu L; Wu L; Yang P Oncol Rep; 2014 Sep; 32(3):1211-7. PubMed ID: 25017650 [TBL] [Abstract][Full Text] [Related]
15. Canagliflozin inhibits p-gp function and early autophagy and improves the sensitivity to the antitumor effect of doxorubicin. Zhong J; Sun P; Xu N; Liao M; Xu C; Ding Y; Cai J; Zhang Y; Xie W Biochem Pharmacol; 2020 May; 175():113856. PubMed ID: 32061772 [TBL] [Abstract][Full Text] [Related]
16. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318. Chen LM; Liang YJ; Ruan JW; Ding Y; Wang XW; Shi Z; Gu LQ; Yang XP; Fu LW J Pharm Pharmacol; 2004 Aug; 56(8):1061-6. PubMed ID: 15285852 [TBL] [Abstract][Full Text] [Related]
17. The multidrug resistance of tumour cells was reversed by tetrandrine in vitro and in xenografts derived from human breast adenocarcinoma MCF-7/adr cells. Fu LW; Zhang YM; Liang YJ; Yang XP; Pan QC Eur J Cancer; 2002 Feb; 38(3):418-26. PubMed ID: 11818209 [TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and bioactivity study on 5-phenylfuran derivatives as potent reversal agents against P-glycoprotein-mediated multidrug resistance in MCF-7/ADR cell. Li YS; Yang X; Zhao DS; Cai Y; Huang Z; Wu R; Wang SJ; Liu GJ; Wang J; Bao XZ; Ye XY; Wei B; Cui ZN; Wang H Eur J Med Chem; 2021 Apr; 216():113336. PubMed ID: 33725657 [TBL] [Abstract][Full Text] [Related]
19. Increase in doxorubicin cytotoxicity by carvedilol inhibition of P-glycoprotein activity. Jonsson O; Behnam-Motlagh P; Persson M; Henriksson R; Grankvist K Biochem Pharmacol; 1999 Dec; 58(11):1801-6. PubMed ID: 10571255 [TBL] [Abstract][Full Text] [Related]
20. Discovery of a novel highly potent and low-toxic jatrophane derivative enhancing the P-glycoprotein-mediated doxorubicin sensitivity of MCF-7/ADR cells. Maimaitijiang A; Wang B; Yang H; Tang D; Liu Y; Aisa HA Eur J Med Chem; 2022 Dec; 244():114822. PubMed ID: 36242992 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]